SCOPUS 정보 검색 플랫폼

American Journal of Cardiology

Volumn 79, Issue 10, 1997, Pages 1387-1388

The clinical therapeutic implications of the Scandinavian Simvastatin Survival Study

(1) Dujovne, Carlos A a,b

a UNIVERSITY OF KANSAS HOSPITAL (United States)

b Division of Clinical Pharmacology (United States)

Author keywords

[No Author keywords available]

Indexed keywords

SIMVASTATIN;

CHOLESTEROL BLOOD LEVEL; CLINICAL PRACTICE; EDITORIAL; FEMALE; FOLLOW UP; HUMAN; HYPERCHOLESTEROLEMIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; REPRODUCIBILITY; SURVIVAL RATE;

ANTICHOLESTEREMIC AGENTS; CORONARY DISEASE; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; LOVASTATIN; MALE; SIMVASTATIN;

EID: 0030945777 PISSN: 00029149 EISSN: None Source Type: Journal
DOI: 10.1016/S0002-9149(97)00145-8 Document Type: Editorial

Times cited : (5)

References (7)

1
- 0027987849
- Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S)
- Scandinavian Simvastatin Survival Study Group. Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: The Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344:1383-1389.
- (1994) Lancet , vol.344 , pp. 1383-1389

2
- 0343702056
- Merck data on file. Merck & Company, Inc., West Point, PA
- Merck data on file. Merck & Company, Inc., West Point, PA.

3
- 0008100135
- The effect of cholesterol lowering with simvastatin on coronary events in diabetic patients with coronary heart disease
- Pyorala K, Pedersen TR, Kjekshus J, for the Scandinavian Simvastatin Survival Study (4S) Group. The effect of cholesterol lowering with simvastatin on coronary events in diabetic patients with coronary heart disease (abstr). Diabetes 1995;44(suppl):35A.
- (1995) Diabetes , vol.44 , Issue.SUPPL.
- Pyorala, K.¹ Pedersen, T.R.² Kjekshus, J.³

4
- 0029883280
- Cholesterol lowering and the use of healthcare resources: Results of the Scandanavian Simvastatin Survival Study
- Pedersen TR, Kjekshus J, Berg K, Olsson AG, Wilhelmsen L, Wedel H, Pyörälä K, Miettinen T, Haghfelt T, Færgeman O, Thorgeirsson G, Jönsson B, Schwartz JS, for the Scandinavian Simvastatin Survival Study Group. Cholesterol lowering and the use of healthcare resources: results of the Scandanavian Simvastatin Survival Study. Circulation 1996;93:1796-1802.
- (1996) Circulation , vol.93 , pp. 1796-1802
- Pedersen, T.R.¹ Kjekshus, J.² Berg, K.³ Olsson, A.G.⁴ Wilhelmsen, L.⁵ Wedel, H.⁶ Pyörälä, K.⁷ Miettinen, T.⁸ Haghfelt, T.⁹ Færgeman, O.¹⁰ Thorgeirsson, G.¹¹ Jönsson, B.¹² Schwartz, J.S.¹³

5
- 0028883828
- Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia
- West of Scotland Coronary Prevention Study Group
- Shepherd J, Cobbe SM, Ford I, Isles CG, Lorimer AR, MacFarlane PW, McKillop HG, Packard CJ. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333:1301-1307.
- (1995) N Engl J Med , vol.333 , pp. 1301-1307
- Shepherd, J.¹ Cobbe, S.M.² Ford, I.³ Isles, C.G.⁴ Lorimer, A.R.⁵ MacFarlane, P.W.⁶ McKillop, H.G.⁷ Packard, C.J.⁸

6
- 33751584473
- Fluvastatin Long-Term Extension Trial (FLUENT): Summary of efficacy and safety
- Davidson MH. Fluvastatin Long-Term Extension Trial (FLUENT): summary of efficacy and safety. Am J Med 1994;96:41S-44S.
- (1994) Am J Med , vol.96
- Davidson, M.H.¹

7
- 0028096810
- A review of clinical trials comparing HMG-CoA reductase inhibitors
- Illingworth DR, Tobert JA. A review of clinical trials comparing HMG-CoA reductase inhibitors. Clin Ther 1994;16:366-385.
- (1994) Clin Ther , vol.16 , pp. 366-385
- Illingworth, D.R.¹ Tobert, J.A.²

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.